Delivery Order SPE2DB20D9331-SPE2DB25FL1T6
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on September 15, 2025, with completion targeted for September 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price delivery order contract with no set-aside designation. The order will be fulfilled from the contractor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-unit quantity). The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The contractor, a...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). This delivery order, issued on May 12, 2025, with an ultimate completion date of May 13, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,868.10 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a product delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a delivery order valued at $42,546.46 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) under a firm fixed-price contract type. This delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a time-sensitive pharmaceutical procurement with no set-aside designation applied. The products will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). This award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, and the product will be delivered to Park Ridge,...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025. This firm fixed-price delivery order, valued at $43,113.50, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to...
- The Defense Logistics Agency awarded a $8,622.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 8, 2025, for the supply of Xtandi 40 mg capsules (quantity: 120 units). The contract, which is set to be completed by September 9, 2025, represents a discrete delivery against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. This delivery order carries no set-aside designation and will be performed at the contractor's facility in Park Ridge,...